Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 3/20/2026Cloudbreak Pharma Withdraws China IND for CBT-009, Refocuses Ophthalmo...
  • 3/20/2026Kintor Reports Positive Phase III Results for First-in-Class Hair Loss...
  • 3/20/2026NovaBridge Secures FDA Alignment on Accelerated Pathway for Givastomig...
  • 3/20/2026ELCC 2026: BioKin–Henlius Combo Shows First-Line Promise in ES-SCLC
  • 3/17/2026Gyre Thera Liver Fibrosis Drug Receives Priority Review in China
  • 3/17/2026Essight Wins FDA Clearance for First Clinical Trial of RAS G12V Bispec...
  • 3/17/2026Fosun Pharma Subsidiary Secures China Approval for Novel Hair-Loss The...
  • 3/16/2026KangaBio Advances Oncology Pipeline with FDA IND Clearance
  • 3/16/20263SBio Wins U.S. FDA Clearance to Advance Metabolic Disease Antibody SS...
  • 3/16/2026CirCode Wins FDA Clearance to Test Circular RNA Therapy
  • 3/13/2026CMS Wins NMPA Approval for Desidustat Tablets to Treat Renal Anemia
  • 3/13/2026UniXell Secures FDA Clearance to Begin Clinical Testing of iPSC-Derive...
  • 3/12/2026Hansoh Launches Phase 3 Trial of B7-H3 ADC HS-20093 With PD-L1 Therapy...
  • 3/10/2026Novo Nordisk and United Labs Report ~20% Weight Loss With Next‑Gen Tr...
  • 3/10/2026Ascletis Reports Positive Phase 2 Results for Monthly ASC30 Obesity Th...
  • 3/10/2026CSPC Subsidiary Registers Phase I/II Trial for In Vivo CD19 CAR-T Ther...
  • 3/10/2026Laekna and Eli Lilly Complete Phase 1 Study of ActRIIA Antibody LAE102...
  • 3/10/2026Junshi Secures NMPA Acceptance for Subcutaneous Toripalimab Across 12 ...
  • 3/9/2026Biocytogen Achieves Key Clinical Milestone as IDEAYA Initiates Phase I...
  • 3/9/2026Regeneron Highlights Positive Chinese Phase III Data for Obesity Candi...
  • 3/9/2026Kelun Biotech and Harbour BioMed's SKB575 Receives IND Clearance in Ch...
  • 3/9/2026Hansoh's B7-H3 ADC Shows Promising Lung Cancer Activity in Cancer Cell...
  • 3/9/2026Hansoh Reports Positive Phase 3 Results for Weekly GLP-1/GIP Dual Agon...
  • 3/9/2026Merck KGaA Drops Hengrui-Licensed PARP1 Candidate After Early Clinical...
  • 3/9/2026Abbisko's Pimicotinib Phase 3 MANEUVER Results Published in The Lancet
  • 3/6/2026China Approves Novo's Weekly Insulin–GLP-1 Combination Therapy for Ty...
  • 3/6/2026Abbisko Doses First Patient in Trial of KRAS G12D Inhibitor ABSK141
  • 3/6/2026Lynk's Zemprocitinib Meets Phase III Endpoints in Atopic Dermatitis
  • 3/6/2026Sciwind's Ecnoglutide Approved in China for Obesity
  • 3/5/2026CMS Wins China Trial Approval for INHBE-Targeting Obesity siRNA Drug
  • Page:1/22 Total number of articles:650: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group